On Cancer

Filter by Tag

Pictured: American Association of Cancer Research Annual Meeting 2012

Announcement

Memorial Sloan-Kettering Discoveries in Personalized Medicine Highlighted at Major Cancer Research Meeting; Investigators Honored

By Media Staff | Tuesday, April 3, 2012

The American Association for Cancer Research (AACR), the world’s oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.

Tags: Cancer Care; Personalized Medicine; Brain Tumors; Chronic Myelogenous Leukemia; Prostate Cancer; Research

In the News

Memorial Sloan-Kettering Made Major Contributions to Cancer Advances in 2011

By Julie Grisham, MS, Science Writer/Editor | Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

Tags: Cancer Care; Personalized Medicine; Targeted Therapy; Melanoma; Ovarian Cancer; Prostate Cancer; Research

Pictured: Charles Sawyers & Howard Scher

In the News

New Medical Strides against Prostate Cancer

By Media Staff | Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Tags: Drug Discovery; Targeted Therapy; Prostate Cancer; Research

Patient Story

Read Michael’s Story about Prostate Cancer Surgery

By Memorial Sloan-Kettering | Thursday, January 19, 2012

When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan-Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.

Tags: Cancer Care; Medical Technology; Surgery; Prostate Cancer

In the Clinic

Bone Scan Index May Help Determine Response to Prostate Cancer Treatment

By Media Staff | Friday, January 13, 2012

Researchers at Memorial Sloan-Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.

Tags: Bone Scan; Cancer Care; Prostate Cancer